A revolutionary tool developed at the University of Texas uses artificial intelligence to speed up the design of mRNA therapies for viruses, cancers, and genetic conditions, cutting development time from months to days.
In a world-first, Johns Hopkins researchers develop an organoid mimicking the entire human brain structure, opening new doors for understanding autism, schizophrenia, and Alzheimer’s.